Bromhexine Hydrochloride + Phenylephrine Hydrochloride + Guaifenesin + Chlorphenamine Maleate + ParacetamolThird Party Manufacturing in India

This multi-ingredient combination works through five distinct pharmacological pathways to provide comprehensive relief from symptoms of the common cold, flu, and upper respiratory tract infections.

Bromhexine Hydrochloride acts as a mucolytic agent, disrupting the structure of acid mucopolysaccharide fibers in sputum to thin and liquefy thick mucus. Guaifenesin, an expectorant, increases the volume and reduces the viscosity of respiratory tract secretions, facilitating the removal of retained mucus by ciliary action and productive coughing. Phenylephrine Hydrochloride is a selective alpha-1 adrenergic receptor agonist that causes vasoconstriction in the nasal mucosa, reducing blood flow, swelling, and nasal congestion. Chlorphenamine Maleate is a first-generation H1-receptor antagonist (antihistamine) that blocks the action of histamine, thereby reducing allergic responses such as runny nose, sneezing, and watery eyes. Paracetamol (Acetaminophen) acts as an analgesic and antipyretic by inhibiting cyclooxygenase (COX) enzymes in the central nervous system, reducing prostaglandin synthesis to alleviate fever, headaches, and general body aches.

Unlike single-ingredient preparations, this combination provides synergetic relief targeting pain, congestion, cough, and allergic symptoms in a single dose. It is widely used and well-tolerated in adult populations when taken as directed.

Therapeutic Uses

This combination tablet is indicated for the temporary relief of symptoms associated with the common cold, influenza, sinusitis, and other upper respiratory tract infections. It is prescribed for:

• Productive Cough and Congestion: Facilitates the clearance of thick mucus while relieving nasal and sinus stuffiness.
• Fever and Body Aches: Alleviates headaches, muscle soreness, sore throat, and high body temperature.
• Allergic Rhinitis Symptoms: Relieves sneezing, runny nose, itching of the nose or throat, and itchy, watery eyes.
• Sinusitis Relief: Decreases pressure and swelling within the sinus cavities to improve airway patency.

Why Manufacturers Choose This Combination

Combining a mucolytic, expectorant, decongestant, antihistamine, and analgesic into a single fixed-dose formulation offers immense value in terms of patient compliance and clinical efficacy. Instead of taking multiple individual medications, patients receive complete symptomatic relief from a single tablet, which significantly reduces the pill burden. This cough and cold segment represents one of the largest market shares in the Indian domestic and export pharmaceutical sectors.

This makes this multi-ingredient formulation highly sought-after for contract and third-party manufacturing in India. The stable demand, coupled with established bioequivalence, makes it a cornerstone product for PCD pharma franchises, OTC brands, and export portfolios targeted at markets in the Middle East, Africa, and Southeast Asia.